280 results on '"Salari, Keyan"'
Search Results
2. Magnetic Resonance Imaging–based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study
3. Incorporating Genetic Risk Into Prostate Cancer Care: Implications for Early Detection and Precision Oncology
4. Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus
5. Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond
6. Novel and Investigational Diagnostics: Liquid Biopsy and Beyond
7. MP31-13 CLINICOPATHOLOGICAL DIFFERENCES BETWEEN ANTERIORLY LOCATED AND PERIPHERAL ZONE PROSTATIC LESIONS DETECTED ON PROSTATE MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING
8. Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer
9. CONDITIONAL SURVIVAL IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
10. CHATGPT USE IN PATIENT AND TRAINEE EDUCATION FOR RENAL MASSES AND RENAL CELL CARCINOMA
11. INTENSIFIED MRI-BASED PROSTATE CANCER SCREENING IN GERMLINE CARRIERS OF RARE PATHOGENIC VARIANTS: INTERIM RESULTS FROM THE INITIAL SCREENING ROUND OF THE PROGRESS STUDY
12. DETECTION, RISK STRATIFICATION, AND THERAPUETIC SELECTION FOR UPPER TRACT UROTHELIAL CARCINOMA WITH URINE-BASED COMPREHENSIVE GENOMIC PROFILING
13. Biologically informed deep neural network for prostate cancer discovery
14. Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancer
15. Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy
16. Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer
17. Transcriptional mediators of treatment resistance in lethal prostate cancer
18. Supplementary Figure 2 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
19. Data from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
20. Supplementary Figure 1 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
21. Supplementary Tables 1-8 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
22. Integrative genomic and functional profiling of the pancreatic cancer genome
23. Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
24. Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer
25. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
26. PD46-07 URINARY COMPREHENSIVE GENOMIC PROFILING AIDS IN DETECTION AND RISK PROGNOSIS OF UPPER TRACT UROTHELIAL CARCINOMA: A CASE-CONTROLLED COHORT STUDY
27. MP40-12 INTENSIFIED PROSTATE CANCER SCREENING IN GERMLINE CARRIERS OF RARE PATHOGENIC VARIANTS: INTERIM RESULTS FROM THE INITIAL SCREENING ROUND OF THE PROGRESS STUDY
28. MP22-19 URINARY COMPREHENSIVE GENOMIC PROFILING PREDICTS UROTHELIAL CANCER UP TO 12 YEARS AHEAD OF CLINICAL DIAGNOSIS. AN EXPANDED ANALYSIS OF THE GOLESTAN COHORT STUDY
29. Supplementary Figures 1-3 from Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer
30. Data from Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
31. Data from Molecular Inversion Probe Analysis of Gene Copy Alterations Reveals Distinct Categories of Colorectal Carcinoma
32. Data from Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer
33. Supplementary Tables 1-6 from Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer
34. Supplementary Figure 1 from Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
35. Supplementary Data 1 from Molecular Inversion Probe Analysis of Gene Copy Alterations Reveals Distinct Categories of Colorectal Carcinoma
36. Supplementary Figure Legends 1-3 from Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer
37. Supplementary Figure 2 from Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
38. Supplementary Table 1 from Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
39. Analysis of evolutionary dynamics and clonal architecture in prostate cancer
40. Integrating artificial intelligence in renal cell carcinoma: evaluating ChatGPT’s performance in educating patients and trainees
41. Prostate cancer single-cell and spatial transcriptomic data analyses
42. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α‐reductase 2
43. Key Notes on Pembrolizumab and Docetaxel Combination Therapy for Metastatic Castration-Resistant Prostate Cancer
44. CDX2 is an amplified lineage-survival oncogene in colorectal cancer
45. MP43-10 IMPACT OF FAMILY HISTORY AND GERMLINE GENETIC RISK VARIANTS ON LONG-TERM OUTCOMES OF ACTIVE SURVEILLANCE-ELIGIBLE PROSTATE CANCER
46. MP54-08 URINARY COMPREHENSIVE GENOMIC PROFILING PREDICTS CLINICAL RECURRENCE IN PATIENTS UNDERGOING SURVEILLANCE FOR UROTHELIAL CARCINOMA
47. Integrated single-cell and spatial transcriptomic analyses unravel the heterogeneity of the prostate tumor microenvironment
48. A machine learning approach to predict progression on active surveillance for prostate cancer
49. Comprehensive genomic profiling of urine DNA for urothelial carcinoma detection and risk prediction.
50. Predicting survival after radical prostatectomy: Variation of machine learning performance by race
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.